Back to Search Start Over

A joint international consensus statement for measuring quality of survival for patients with childhood cancer.

Authors :
van Kalsbeek RJ
Hudson MM
Mulder RL
Ehrhardt M
Green DM
Mulrooney DA
Hakkert J
den Hartogh J
Nijenhuis A
van Santen HM
Schouten-van Meeteren AYN
van Tinteren H
Verbruggen LC
Conklin HM
Jacola LM
Webster RT
Partanen M
Kollen WJW
Grootenhuis MA
Pieters R
Kremer LCM
Source :
Nature medicine [Nat Med] 2023 Jun; Vol. 29 (6), pp. 1340-1348. Date of Electronic Publication: 2023 Jun 15.
Publication Year :
2023

Abstract

The aim of treating childhood cancer remains to cure all. As survival rates improve, long-term health outcomes increasingly define quality of care. The International Childhood Cancer Outcome Project developed a set of core outcomes for most types of childhood cancers involving relevant international stakeholders (survivors; pediatric oncologists; other medical, nursing or paramedical care providers; and psychosocial or neurocognitive care providers) to allow outcome-based evaluation of childhood cancer care. A survey among healthcare providers (nā€‰=ā€‰87) and online focus groups of survivors (nā€‰=ā€‰22) resulted in unique candidate outcome lists for 17 types of childhood cancer (five hematological malignancies, four central nervous system tumors and eight solid tumors). In a two-round Delphi survey, 435 healthcare providers from 68 institutions internationally (response rates for round 1, 70-97%; round 2, 65-92%) contributed to the selection of four to eight physical core outcomes (for example, heart failure, subfertility and subsequent neoplasms) and three aspects of quality of life (physical, psychosocial and neurocognitive) per pediatric cancer subtype. Measurement instruments for the core outcomes consist of medical record abstraction, questionnaires and linkage with existing registries. This International Childhood Cancer Core Outcome Set represents outcomes of value to patients, survivors and healthcare providers and can be used to measure institutional progress and benchmark against peers.<br /> (© 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.)

Details

Language :
English
ISSN :
1546-170X
Volume :
29
Issue :
6
Database :
MEDLINE
Journal :
Nature medicine
Publication Type :
Academic Journal
Accession number :
37322119
Full Text :
https://doi.org/10.1038/s41591-023-02339-y